אזטימיב
הערות שוליים

1 2 3  Ezetimibe Monograph for Professionals, Drugs.com (באנגלית)
1 2 3 4  BNF 76: September 2018, september 2018 - march 2019, London: Pharmaceutical Press, 2018, British National Formulary, ISBN 978-0-85711-338-2
↑  The Top 300 of 2022, clincalc.com
↑  Ezetimibe - Drug Usage Statistics, ClinCalc DrugStats Database, clincalc.com
↑  Gianluigi Savarese, Gaetano M. De Ferrari, Giuseppe M.C. Rosano, Pasquale Perrone-Filardi, Safety and efficacy of ezetimibe: A meta-analysis, International Journal of Cardiology 201, 2015-12, עמ' 247–252 doi: 10.1016/j.ijcard.2015.08.103
1 2  Peter Toth, Phan, Thomas Dayspring, Ezetimibe therapy: mechanism of action and clinical update, Vascular Health and Risk Management, 2012-07, עמ' 415 doi: 10.2147/VHRM.S33664
↑  Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano, Amy McCagg, Jennifer A. White, Pierre Theroux, Harald Darius, Basil S. Lewis, Ton Oude Ophuis, J. Wouter Jukema, Gaetano M. De Ferrari, Witold Ruzyllo, Paul De Lucca, KyungAh Im, Erin A. Bohula, Craig Reist, Stephen D. Wiviott, Andrew M. Tershakovec, Thomas A. Musliner, Eugene Braunwald, Robert M. Califf, Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes, New England Journal of Medicine 372, 2015-06-18, עמ' 2387–2397 doi: 10.1056/NEJMoa1410489
↑  Francis J. Alenghat, Andrew M. Davis, Management of Blood Cholesterol, JAMA 321, 2019-02-26, עמ' 800 doi: 10.1001/jama.2019.0015
↑  Kunal Mahajan, Lakshmi Nagendra, Anil Dhall, Deep Dutta, Impact of early initiation of ezetimibe in patients with acute coronary syndrome: A systematic review and meta-analysis, European Journal of Internal Medicine 124, 2024-06, עמ' 99–107 doi: 10.1016/j.ejim.2024.02.004
1 2 3 4 5 6  DailyMed - ZETIA - ezetimibe tablet, dailymed.nlm.nih.gov
↑  on behalf of Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group, Kamal Awad, Dimitri P. Mikhailidis, Niki Katsiki, Paul Muntner, Maciej Banach, Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Drugs 78, 2018-03, עמ' 453–462 doi: 10.1007/s40265-018-0870-1
↑  Hyo Young Lee, Dae Won Jun, Hyun Jung Kim, Hyunwoo Oh, Waqar Khalid Saeed, Hyeongsik Ahn, Ramsey C. Cheung, Mindie H. Nguyen, Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis, The Korean Journal of Internal Medicine 34, 2019-03-01, עמ' 296–304 doi: 10.3904/kjim.2017.194
1 2  Tappei Takada, Yoshihide Yamanashi, Kentaro Konishi, Takehito Yamamoto, Yu Toyoda, Yusuke Masuo, Hideaki Yamamoto, Hiroshi Suzuki, NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy, Science Translational Medicine 7, 2015-02-18 doi: 10.1126/scitranslmed.3010329
↑  Rezarta Islamaj, Robert Leaman, Sun Kim, Dongseop Kwon, Chih-Hsuan Wei, Donald C. Comeau, Yifan Peng, David Cissel, Cathleen Coss, Carol Fisher, Rob Guzman, Preeti Gokal Kochar, Stella Koppel, Dorothy Trinh, Keiko Sekiya, Janice Ward, Deborah Whitman, Susan Schmidt, Zhiyong Lu, NLM-Chem, a new resource for chemical entity recognition in PubMed full text literature, Scientific Data 8, 2021-03-25 doi: 10.1038/s41597-021-00875-1
↑  Shaik Jafar Sadik Basha, Shaik Abdul Naveed, Nirbhay Kumar Tiwari, Dhanya Shashikumar, Syed Muzeeb, Thammera Ranjith Kumar, Nyavanandi Vijay Kumar, Nadipalli Prabhakar Rao, Nanduri Srinivas, Ramesh Mullangi, Nuggehally R. Srinivas, Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: Quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bile, Journal of Chromatography B 853, 2007-06, עמ' 88–96 doi: 10.1016/j.jchromb.2007.02.053
↑  Mara Monetti, Malin C. Levin, Matthew J. Watt, Mini P. Sajan, Stephen Marmor, Brian K. Hubbard, Robert D. Stevens, James R. Bain, Christopher B. Newgard, Robert V. Farese, Andrea L. Hevener, Robert V. Farese, Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver, Cell Metabolism 6, 2007-07, עמ' 69–78 doi: 10.1016/j.cmet.2007.05.005
↑  Patrick W. O'Donnell, Anthony M. Griffin, William C. Eward, Amir Sternheim, Lawrence M. White, Jay S. Wunder, Peter C. Ferguson, Can Experienced Observers Differentiate between Lipoma and Well-Differentiated Liposarcoma Using Only MRI?, Sarcoma 2013, 2013, עמ' 1–6 doi: 10.1155/2013/982784
↑  Paolo Ciana, Michele Raviscioni, Paola Mussi, Elisabetta Vegeto, Ivo Que, Malcolm G. Parker, Clemens Lowik, Adriana Maggi, In vivo imaging of transcriptionally active estrogen receptors, Nature Medicine 9, 2003-01, עמ' 82–86 doi: 10.1038/nm809
↑  Eydie L. Moses-Kolko, Carolyn Cidis Meltzer, Joseph C. Helsel, Michael Sheetz, Chestera Mathis, James Ruszkiewicz, Debra Bogen, Andrea L. Confer, Katherine L. Wisner, No interruption of lactation is needed after (11)C-WAY 100635 or (11)C-raclopride PET, Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 46, 2005-10, עמ' 1765
↑  C. A. Wasywich, P. N. Ruygrok, L. Wilkinson, H. Gibbs, H. A. Coverdale, Planned pregnancy in a heart transplant recipient, Internal Medicine Journal 34, 2004-04, עמ' 206–209 doi: 10.1111/j.1444-0903.2004.00530.x
↑  Statins Post-PCI: Moderate-Intensity and Add Ezetimibe?, Medscape (באנגלית)
↑  Yong-Joon Lee, Jae Young Cho, Seng Chan You, Yong-Ho Lee, Kyeong Ho Yun, Yun-Hyeong Cho, Won-Yong Shin, Sang Wook Im, Woong Chol Kang, Yongwhi Park, Sung Yoon Lee, Seung-Jun Lee, Sung-Jin Hong, Chul-Min Ahn, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Jung-Sun Kim, Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial, European Heart Journal 44, 2023-03-14, עמ' 972–983 doi: 10.1093/eurheartj/ehac709
1 2  Ezetimibe (Zetia) Use During Pregnancy, Drugs.com (באנגלית)